Cargando…
Interleukin-2 in Renal Cell Carcinoma: A Has-Been or a Still-Viable Option?
Modulation of the immune response plays an important role in the natural history of renal cell carcinoma. Spontaneous regression of metastases has been well documented in a small percentage of patients after they undergo de-bulking nephrectomy without any additional systemic intervention. The only l...
Autores principales: | Amin, Asim, White, Richard L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Codon Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345537/ https://www.ncbi.nlm.nih.gov/pubmed/28326252 http://dx.doi.org/10.15586/jkcvhl.2014.18 |
Ejemplares similares
-
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
por: Han, Ruofan Connie, et al.
Publicado: (2021) -
Porous Tantalum Implant in Treating Osteonecrosis of the Femoral Head: Still a Viable Option?
por: Ma, Jinhui, et al.
Publicado: (2016) -
10th Anniversary of a Two-Stage Design in Bioequivalence. Why Has it Still Not Been Implemented?
por: Kaza, Michał, et al.
Publicado: (2020) -
Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
por: Bohn, Jan-Paul, et al.
Publicado: (2016) -
Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
por: Bonny-Noach, Hagit
Publicado: (2019)